why choose us

First received: May 03, 2023

Clinical Trial: Tumor-Derived FGF19

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer

Study Type: OBSERVATIONAL


Official Title: Translational Utility of Tumor-Derived FGF19 in a Novel Blood-Based Endocrine Suppression Approach

Brief Summary: Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls

Read more